ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Regencell Bioscience Holdings Limited (RGC) stock surged +18.67%, trading at $37.50 on NASDAQ, up from the previous close of $31.60. The stock opened at $31.60, fluctuating between $31.60 and $37.50 in the recent session.
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Employees | 12 |
Beta | -4.3 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | June |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep